to the carrying amount of assets related to the license. Conclusions: The Group reported operations for the nine-month period ended 30 September 2017 represented had a loss of Baht 718.18 million

Group reported a loss for the nine-month period ended 30 September 2017 to be Baht 2,135.17 million. Compared to the same period of 2016, the loss was Baht 622.76 million.

results for the year ended 31th December 2017, compared to those for the same period ended 31th December 2016. The consolidated financial statements reported a net loss of Baht 46.53 million and Baht 78.37

revenue guidance while others maintained 3Q20 reported core service revenue was -6.8%YoY and flat QoQ from prolonged impact of pandemic. EBITDA ( pre- TFRS16) declined -11%YoY and -1.4% QoQ with continued

results for the 1st quarter ended 31th March 2019, compared to those for the same period ended 31th March 2018. The consolidated financial statements reported a net loss of Baht 3.85 million and net profit

31, 2019 as follows: The Company reported net profit for the first quarter 2019 of Baht 0.98 million, comparing with the same period last year which had net loss of Baht 41.94 million, increasing by

results for the 2nd quarter ended 30th June 2019, compared to those for the same period ended 30th June 2018. The consolidated financial statements reported a net profit of Baht 1.45 million and net profit

the company was able to utilize the deferred tax asset, which was non-cash item. Net Profit Reported net profit of the company for the period of Q3’2018-2019 was Baht 422 million, rose by Baht 130

recognition from the In Vitro Fertilization center. The financial position of the company according to the consolidated financial statements as of 30th June 2018, the company reported total assets at THB 870.72

results for the 2nd quarter ended 30th June 2018, compared to those for the same period ended 30th June 2017. The consolidated financial statements reported a net profit of Baht 11.00 million and net loss